1. Home
  2. CMCO vs LRMR Comparison

CMCO vs LRMR Comparison

Compare CMCO & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

BUY

Current Price

$15.98

Market Cap

483.0M

Sector

Industrials

ML Signal

BUY

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

SELL

Current Price

$2.70

Market Cap

455.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CMCO
LRMR
Founded
1875
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.0M
455.8M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CMCO
LRMR
Price
$15.98
$2.70
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
★ $26.00
$14.40
AVG Volume (30 Days)
340.5K
★ 1.4M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $936,240,000.00
N/A
Revenue This Year
$76.00
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.27
N/A
52 Week Low
$11.99
$2.72
52 Week High
$24.40
$6.42

Technical Indicators

Market Signals
Indicator
CMCO
LRMR
Relative Strength Index (RSI) 44.41 24.50
Support Level $14.88 N/A
Resistance Level $16.42 $3.76
Average True Range (ATR) 0.70 0.19
MACD 0.04 -0.08
Stochastic Oscillator 36.18 5.24

Price Performance

Historical Comparison
CMCO
LRMR

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: